SCHEMBL10724191

SCHEMBL10724191

O=CC(N1CCNCC1)n1c(=O)sc2ccc(Cl)cc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TMEM97 Q5BJF2 3/20 0.41
▸ CYP2D6 P10635 2/20 0.37
▸ CYP19A1 P11511 1/20 0.37
▸ USP2 O75604 1/20 0.36
▸ HTR2A P28223 3/20 0.35
▸ HTR2C P28335 3/20 0.35
▸ NPY5R Q15761 3/20 0.34
▸ SLC6A4 P31645 4/20 0.33
▸ ADRB1 P08588 2/20 0.33
▸ HTR6 P50406 2/20 0.33
▸ SIGMAR1 Q99720 2/20 0.33
▸ SLC6A2 P23975 2/20 0.33
▸ HTR3E A5X5Y0 1/20 0.33
▸ HTR3B O95264 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ HTR1A P08908 1/20 0.33
▸ THRB P10828 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10724198 0.86 TMEM97 (0.41) TMEM97NPY5RSIGMAR1
Hydrochloric Acid SCHEMBL10721606 0.85 TMEM97 (0.40) TMEM97NPY5RSIGMAR1
SCHEMBL10656985 0.84 TMEM97 (0.40) TMEM97NPY5R
SCHEMBL10720127 0.84 TMEM97 (0.40) TMEM97NPY5RSIGMAR1
Hydrochloric Acid SCHEMBL10723941 0.83 TMEM97 (0.39) TMEM97NPY5RSIGMAR1
Hydrochloric Acid SCHEMBL10721852 0.82 TMEM97 (0.38) TMEM97NPY5RSIGMAR1
SCHEMBL10723450 0.81 HRH4 (0.35) CYP2D6CYP19A1HTT
SCHEMBL10974768 0.81 TMEM97 (0.47) TMEM97CYP2D6USP2HTR2AHTR2C
SCHEMBL8894960 0.80 TMEM97 (0.49) TMEM97CYP2D6SIGMAR1TP53CYP3A4
SCHEMBL10724235 0.79 TMEM97 (0.36) TMEM97NPY5RSIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0232740-A1 N-containing fused heterocyclic compounds, processes for the preparation thereof and pharmaceutical compositions comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-08-19 — — EP disclosed
Send feedback